The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J

被引：343

作者：

Levitus, M

Waisfisz, Q

Godthelp, BC

de Vries, Y

Hussain, S

Wiegant, WW

Elghalbzouri-Maghrani, E

Steltenpool, J

Rooimans, MA

Pals, G

Arwert, F

Mathew, CG

Zdzienicka, MZ

Hiom, K

De Winter, JP

Joenje, H

机构：

[1] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet & Human Genet, NL-1081 BT Amsterdam, Netherlands

[2] Leiden Univ, Med Ctr, Dept Toxicogenet, NL-2333 AL Leiden, Netherlands

[3] Kings Coll London, Guys Hosp, Div Med & Mol Genet, London, England

[4] Nicholas Copernicus Univ, Coll Med L Rydygier, Dept Mol Cell Genet, Bydgoszcz, Poland

[5] MRC, Mol Biol Lab, Cambridge CB2 2QH, England

来源：

NATURE GENETICS | 2005年 / 37卷 / 09期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1038/ng1625

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

The protein predicted to be defective in individuals with Fanconi anemia complementation group J ( FA- J), FANCJ, is a missing component in the Fanconi anemia pathway of genome maintenance. Here we identify pathogenic mutations in eight individuals with FA- J in the gene encoding the DEAH- box DNA helicase BRIP1, also called FANCJ. This finding is compelling evidence that the Fanconi anemia pathway functions through a direct physical interaction with DNA.

引用

页码：934 / 935

页数：2

共 10 条

[1] The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair
Bridge, WL
Vandenberg, CJ
Franklin, RJ
Hiom, K
[J]. NATURE GENETICS, 2005, 37 (09) : 953 - 957
[2] The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations
Cantor, S
Drapkin, R
Zhang, F
Lin, YF
Han, JL
Pamidi, S
Livingston, DM
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (08) : 2357 - 2362
[3] BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function
Cantor, SB
Bell, DW
Ganesan, S
Kass, EM
Drapkin, R
Grossman, S
Wahrer, DCR
Sgroi, DC
Lane, WS
Haber, DA
Livingston, DM
[J]. CELL, 2001, 105 (01) : 149 - 160
[4] Microcell-mediated chromosome transfer (MMCT): small cells with huge potential
Doherty, AMO
Fisher, EMC
[J]. MAMMALIAN GENOME, 2003, 14 (09) : 583 - 592
[5] The emerging genetic and molecular basis of Fanconi anaemia
Joenje, H
Patel, KJ
[J]. NATURE REVIEWS GENETICS, 2001, 2 (06) : 446 - 457
[6] Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes
Levitus, M
Rooimans, MA
Steltenpool, J
Cool, NFC
Oostra, AB
Mathew, CG
Hoatlin, ME
Waisfisz, Q
Arwert, F
de Winter, JP
Joenje, H
[J]. BLOOD, 2004, 103 (07) : 2498 - 2503
[7] A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M
Meetei, AR
Medhurst, AL
Ling, C
Xue, YT
Singh, TR
Bier, P
Steltenpool, J
Stone, S
Dokal, I
Mathew, CG
Hoatlin, M
Joenje, H
de Winter, JP
Wang, WD
[J]. NATURE GENETICS, 2005, 37 (09) : 958 - 963
[8] Crosslinks and crosstalk: Human cancer syndromes and DNA repair defects
Risinger, MA
Groden, J
[J]. CANCER CELL, 2004, 6 (06) : 539 - 545
[9] CLONING OF CDNAS FOR FANCONIS ANEMIA BY FUNCTIONAL COMPLEMENTATION
STRATHDEE, CA
GAVISH, H
SHANNON, WR
BUCHWALD, M
[J]. NATURE, 1992, 356 (6372) : 763 - 767
[10] The BRCT domain is a phospho-protein binding domain
Yu, XC
Chini, CCS
He, M
Mer, G
Chen, JJ
[J]. SCIENCE, 2003, 302 (5645) : 639 - 642

← 1 →